3.0705.54% ( -0.180 )
Delay Closed: Nov 17, 16:08:15Valuation
Current ValuationThe current P/E ratio is 9.94, below the reasonable range, cheaper than 99.62% of the time in the past 1 years, and the industry ranks 6/22, the industry Median 6.31.
9.94xP/E
HK$3.07Stock price
HK$0.31Earnings per share
9.94xP/E
Stock priceHK$3.07Earnings per shareHK$0.31
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 17.89x
- Typical range
- 11.50x–39.21x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.31x
05101520
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.31x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
01099HKSINOPHARM | 6.31x | 10.33% | HK$52.65B |
02607HKSH PHARMA | 6.73x | -- | HK$40.50B |
00874HKBAIYUNSHAN PH | 8.10x | 8.46% | HK$20.42B |
09885HKYSB | 9.94x | -- | HK$2.13B |
06833HKSINCO PHARMA | 7.67x | -- | HK$268.34M |
03390HKTYCOON GROUP | 6.77x | -- | HK$208.30M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
